Novartis AG

NVS·NYSE·$150.80Share Price as of 11/2·$288BMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)02/04/26 20-FAnnual report (foreign)01/31/25 20-FAnnual report (foreign)01/31/24 20-F/AAnnual report (foreign, amended)05/15/23 20-FAnnual report (foreign)02/01/23

Disclosures

6-KForeign issuer report10/27/26 6-KForeign issuer report09/08/26 6-KForeign issuer report09/04/26 6-KForeign issuer report09/01/26 6-KForeign issuer report07/21/26

Prospectuses and Registrations

424B5Prospectus supplement03/17/26 FWPFree writing prospectus03/17/26 424B5Prospectus supplement03/16/26 S-8Registration of securities for employees02/04/26 S-8 POSPost-effective amendment (S-8)01/16/26

Proxies

DFAN14AAdditional materials (non-management)01/14/26 DFAN14AAdditional materials (non-management)01/12/26 DFAN14AAdditional materials (non-management)10/28/25 DFAN14AAdditional materials (non-management)10/28/25 DFAN14AAdditional materials (non-management)10/27/25

Ownership

144Proposed sale of securities10/28/26 144Proposed sale of securities04/30/26 144Proposed sale of securities02/12/26 144Proposed sale of securities02/09/26 Form 3Initial insider ownership10/28/25

Other

IRANNOTICEIran disclosure02/04/26 SC TO-T/ASC TO-T/A10/28/25 SC TO-T/ASC TO-T/A10/22/25 SC TO-T/ASC TO-T/A10/20/25 SC TO-TThird party tender offer09/29/25